Ironwood Pharmaceuticals, Inc. (IRWD)
4.165
-0.06
(-1.30%)
USD |
NASDAQ |
May 11, 16:00
4.07
-0.10
(-2.28%)
After-Hours: 17:50
Ironwood Pharmaceuticals Shareholders Equity (Quarterly) : -217.14M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -6.656B |
| Recursion Pharmaceuticals, Inc. | 1.025B |
| Cytokinetics, Inc. | -826.57M |
| Geron Corp. | 229.11M |
| Gilead Sciences, Inc. | 23.52B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 434.57M |
| Total Liabilities (Quarterly) | 651.71M |
| Debt to Equity Ratio | -2.751 |
| Current Ratio | 1.406 |
| Net Debt Paydown Yield | 0.07% |